Static vs Cidal Antibiotics: Concepts Revisited
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Static vs Cidal Antibiotics: Concepts Revisited
-
Narrated by:
-
By:
About this listen
A common description of antibiotic action aims to classify them between “bactericidal” or “bacteriostatic”. Although these phenomena have robust in vitro foundations, the clinical translation of these concepts is sometimes difficult to ascertain. This controversial topic has important conceptual ramifications to treat severe infections. Today, we will discuss this topic with an expert in field.
Watch the video version here: https://youtu.be/3z4BItBrzbk
Topics discussed:- The definitions of “cidal” vs “static” antibiotics
- The clinical applicability of the above terms in terms of antibiotic choice and syndromatic approaches
- antibiotic choices and the controversy between bactericidal and bacteriostatic antibiotics.
- Brad Spellberg, MD. Chief Medical Officer at the Los Angeles General Medical Center
- ASM and IDSA launch the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) in 2026
- Watch this session on YouTube
This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal.
Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.
No reviews yet